Carsten Brunn - Net Worth and Insider Trading

Carsten Brunn Net Worth

The estimated net worth of Carsten Brunn is at least $2 Million dollars as of 2025-07-02. Carsten Brunn is the President and CEO of Cartesian Therapeutics Inc and owns about 204,096 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $2 Million. Details can be seen in Carsten Brunn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carsten Brunn has not made any transactions after 2025-01-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Carsten Brunn

To

Carsten Brunn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carsten Brunn owns 2 companies in total, including Cartesian Therapeutics Inc (RNAC) , and Surface Oncology Inc (SURF) .

Click here to see the complete history of Carsten Brunn’s form 4 insider trades.

Insider Ownership Summary of Carsten Brunn

Ticker Company Transaction Date Type of Owner
RNAC Cartesian Therapeutics Inc 2025-01-06 director & President & CEO
SURF Surface Oncology Inc 2022-06-28 director

Carsten Brunn Latest Holdings Summary

Carsten Brunn currently owns a total of 1 stock. Carsten Brunn owns 204,096 shares of Cartesian Therapeutics Inc (RNAC) as of January 6, 2025, with a value of $2 Million.

Latest Holdings of Carsten Brunn

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RNAC Cartesian Therapeutics Inc 2025-01-06 204,096 10.89 2,222,605

Holding Weightings of Carsten Brunn


Carsten Brunn Form 4 Trading Tracker

According to the SEC Form 4 filings, Carsten Brunn has made a total of 13 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Cartesian Therapeutics Inc is the sale of 17,271 shares on January 6, 2025, which brought Carsten Brunn around $289,807.

Insider Trading History of Carsten Brunn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carsten Brunn Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carsten Brunn Ownership Network

Ownership Network List of Carsten Brunn

No Data

Ownership Network Relation of Carsten Brunn

Insider Network Chart


Carsten Brunn Owned Company Details

What does Cartesian Therapeutics Inc do?

Who are the key executives at Cartesian Therapeutics Inc?

Carsten Brunn is the director & President & CEO of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Financial Officer Blaine Davis , Chief Medical Officer Peter G Traber , and Chief Scientific Officer Takashi Kei Kishimoto .

Cartesian Therapeutics Inc (RNAC) Insider Trades Summary

Over the past 18 months, Carsten Brunn made 1 insider transaction in Cartesian Therapeutics Inc (RNAC) with a net sale of 17,271. Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 2,181,087 shares made by Timothy A Springer , a net sale of 1,797 shares made by , and a net sale of 7,989 shares made by Blaine Davis .

In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 149,075 shares, with a net purchase of 149,075 shares. During the past 18 months, 278,198 shares of Cartesian Therapeutics Inc (RNAC) were sold and 1,006,048 shares were bought by its insiders, resulting in a net purchase of 727,850 shares.

Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cartesian Therapeutics Inc Insider Transactions

No Available Data

Carsten Brunn Mailing Address

Above is the net worth, insider trading, and ownership report for Carsten Brunn. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Carsten Brunn's mailing address is: Watertown Ma 02472.